Business Context and Reporting Period
This Form 8-K Current Report was filed by GoodRx Holdings, Inc. on January 13, 2025, covering events occurring on January 7, 2025. The filing addresses a significant leadership transition within the company's finance department.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure of CFO: Karsten Voermann resigned as Chief Financial Officer effective January 17, 2025, citing personal reasons. The resignation was not due to any disagreement regarding company operations or policies.
- Appointment of Interim CFO: Romin Nabiey, the current Chief Accounting Officer, was appointed as Interim Chief Financial Officer effective January 17, 2025. He will also serve as the principal financial officer while continuing his role as Chief Accounting Officer.
- Succession Plan: The Board of Directors has initiated a search to identify a permanent successor to the CFO role.
Outlook, Risks, and Unusual Items
Separation Agreement: The Company expects to enter into a Separation Agreement & Release with Mr. Voermann. Key terms include:
- Outstanding and vested stock options will remain exercisable through January 17, 2026.
- Mr. Voermann is entitled to receive any earned 2024 annual cash incentive bonus.
- Mr. Voermann will release the Company from claims arising prior to the effective date, subject to legal exceptions.
- The agreement includes non-disparagement clauses and standard confidentiality covenants.
Risk Factors: The filing notes no material disagreements or unusual items related to the departure. The transition is described as amicable.
Investor Verification Checklist
- Confirm the timeline for the permanent CFO search and any interim financial reporting impacts.
- Review the final executed Separation Agreement for any additional compensation details not yet finalized.
- Monitor future filings for the appointment of a permanent Chief Financial Officer.
- Verify that Romin Nabiey's dual role as Interim CFO and Chief Accounting Officer does not create internal control conflicts.